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537Sp1-mediated transcription is involved in the induction of
leptin by insulin-stimulated glucose metabolismM J Moreno-Aliaga, M M Swarbrick1, S Lorente-Cebria´n, K L Stanhope1, P J Havel1
and J A Martı´nez
Department of Physiology and Nutrition, School of Pharmacy, University of Navarra, 31008 Pamplona, Spain
1Department of Nutrition, University of California, Davis, One Shields Avenue, Davis, California 95616, USA
(Requests for offprints should be addressed to M J Moreno-Aliaga; Email: mjmoreno@unav.es)AbstractWehave previously demonstrated that insulin-stimulated glucosemetabolism, and not insulin per se, mediates the effects
of insulin to increase the transcriptional activity of the leptin promoter in adipocytes. Here, we sought to identify the specific
cis-acting DNA elements required for the upregulation of leptin gene transcription in response to insulin-mediated glucose
metabolism. To accomplish this, 3T3-L1 cells and primary rat adipocytes were transfected with a series of luciferase
reporter genes containing portions of the mouse leptin promoter. Using this method, we identified an element between
K135 andK95 bp (relative to the transcriptional start site) that mediated transcription in response to insulin-stimulated
glucosemetabolism in adipocytes. This effect was abolished by incubation with 2-deoxy-D-glucose, a competitive inhibitor
of glucose metabolism. Gel shift electrophoretic mobility shift assays confirmed that the stimulatory effect of insulin-
mediated glucose metabolism on leptin transcription was mediated by a previously identified Sp1 site. Consistent with
these findings, incubation of primary rat adipocytes withWP631, a specific inhibitor of specificity protein (Sp)1-dependent
transcription, inhibited glucose- and insulin-stimulated, but not basal, leptin secretion. Together, these findings support a
key role for Sp1 in the transcriptional activation of the leptin gene promoter by insulin-mediated glucose metabolism.Journal of Molecular Endocrinology (2007) 38, 537–546Introduction
Leptin is a 167 amino acid-secreted protein produced
mainly by adipocytes that maintains energy homeostasis
by exerting pleiotropic effects on energy intake and
energyexpenditure (Havel 2004).Leptin actsprimarily as
a signal of nutritional deprivation, where decreases of
circulating leptin initiate an adaptive response to
conserve energy, characterized by hyperphagia,
decreased energy expenditure and inhibition of repro-
ductive, and other endocrine systems. Genetic deficiency
of either leptin or its receptor inmice andhumans results
in severe early onset obesity (Farooqi & O’Rahilly 2005).
A more complete understanding of the molecular and
biochemical mechanisms regulating leptin secretion in
adipocytesmay lead to new therapeutic opportunities for
managing obesity and related metabolic diseases (Havel
2004, Rosenbaum et al. 2005). Several major signaling
systems affecting leptin production have been identified.
Leptin synthesis and secretion are increased by insulin
(Saladin et al.1995, Leroy et al. 1996, Bradley&Cheatham
1999) andglucocorticoids (Slieker et al. 1996, Kolaczynski
et al. 1997), and are inhibited by adrenergic agonists
(Trayhurn et al. 1996, Moreno-Aliaga et al. 2002) and
activators of peroxisome proliferator activated receptor
(PPAR)-g, such as thiazolidinediones (De Vos et al. 1996).Journal of Molecular Endocrinology (2007) 38, 537–546
0952–5041/07/038–537 q 2007 Society for Endocrinology Printed in Great BritainWe have demonstrated previously that insulin-stimu-
lated glucose metabolism, rather than a direct effect of
insulin per se, mediates the actions of insulin to increase
the leptin (ob) gene expression and leptin secretion in
isolated adipocytes (Mueller et al. 1998). During
incubation of isolated adipocytes with physiological
concentrations of insulin (0.16–16 nM), we demon-
strated that the increase of leptin secretion was much
more closely related to the amount of glucose taken up
by the adipocytes than to the concentration of insulin.
Consistent with this finding, competitive inhibition
of glucose transport and phosphorylation with 2-deoxy-
D-glucose (2-DG) caused a concentration-dependent
inhibition of leptin release in the presence of 1.6 nM
insulin. Other inhibitors of glucose transport
(phloretin and cytochalasin B) or metabolism (iodoa-
cetate and fluoride) also inhibited leptin secretion, in
direct proportion to glucose uptake (Mueller et al.
1998). Additional studies suggested that, not only
glucose uptake, but also oxidative metabolism of
glucose beyond pyruvate, is required for insulin-
mediated leptin secretion (Mueller et al. 2000). We have
also demonstrated that insulin-mediated glucose meta-
bolism is involved in the activation of the leptin
promoter transcription by glucose and insulin in 3T3-
L1 cells (Moreno-Aliaga et al. 2001).DOI: 10.1677/JME-06-0034
Online version via http://www.endocrinology-journals.org
M J MORENO-ALIAGA and others . Sp1 and regulation of leptin538While the structure of the promoter region has been
well characterized, there is a paucity of datawhichdirectly
addresses the question of how insulin-stimulated glucose
metabolism stimulates leptin synthesis in adipocytes.
Fukuda & Iritani (1999) joined two copies of the rat
leptin promoter sequence from K101 to K83 (which
contains a consensus Sp1-binding site) to a luciferase
reporter gene, and found that the activity of this reporter
gene in transfected primary rat adipocytes was upregu-
lated by the addition of 0.1 mM insulin compared with
incubation in 20 mM glucose alone. Mutation of this Sp1
site in the reporter gene then abolished its responsiveness
to glucose and insulin. Other studies have mutated the
equivalent Sp1 site in the proximal human (Zhang et al.
2002) and murine (Mason et al. 1998) promoters and
have also observed a reduction in reporter gene activity.
Subsequent gel shift experiments by Fukuda & Iritani
(1999) confirmed the binding of a protein from adipose
tissue nuclear extract to the K101 to K83 sequence.
Formation of this DNA–protein complex was inhibited to
some degree by competition with a DNA probe
containing an Sp1-binding sequence and also by
preincubation with an anti-Sp1 antibody. A recent study
also observed that mutation in Sp1 motif of the bovine
leptin gene decreases the promoter-binding capacity for
nuclear proteins and reduces leptin gene expression
(Adamowicz et al. 2006).
Overall, these data indicate that insulin-stimulated
glucose metabolism might activate Sp1-mediated tran-
scription of leptin via this Sp1 site in the proximal
promoter. However, in the experiments of Fukuda &
Iritani (1999), co-transfection of an Sp1 expression
vector with their reporter gene decreased promoter
activity in adipocytes, suggesting that Sp1 inhibited
transcription through this element. This result was
clearly inconsistent with the prevailing view that
deletion of the Sp1 site reduces promoter activity in
adipocytes (Mason et al. 1998, Fukuda & Iritani 1999,
Zhang et al. 2002).
Therefore, the aim of the present study was to
investigate the mechanisms underlying the transcrip-
tional regulation of the leptin gene by insulin-
stimulated glucose metabolism. First, we carried out
deletion mapping studies in adipocytes to identify the
cis-acting DNA sequences in the proximal promoter
mediating the effects of insulin-stimulated glucose
metabolism to increase leptin gene transcription.
Secondly, we performed electrophoretic mobility shift
assays (EMSAs) to test the hypothesis that the
transcription factor Sp1 mediates the stimulatory effects
of insulin-mediated glucose metabolism. Finally, we
incubated primary adipocyte cultures with a specific
inhibitor of Sp1-mediated transcription and found that
while this intervention had no effect on basal leptin
secretion, it abolished insulin-stimulated leptin
secretion.Journal of Molecular Endocrinology (2007) 38, 537–546Materials and methods
Cell culture and differentiation
Low-passage (3–9) 3T3-L1 cells (American Type Culture
Collection, Rockville, MD, USA) were used in all studies.
Cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 25 mM glucose and 10%
calf serum, and were maintained in a water-jacketed
incubator set to 37 8C and 5% carbon dioxide. Confluent
cells were induced to differentiate by incubating for 72 h
with differentiation medium containing 1 mM dexa-
methasone, 0.5 mM isobutylmethylxanthine (IBMX),
and 10% fetal bovine serum in DMEM. Cells were then
maintained in DMEM containing 10% fetal bovine
serum, but without dexamethasone or IBMX (post-
differentiation medium), for 48 h prior to transfection.Primary culture of adipocytes
Adipocyteswere isolated fromepididymal fat padsofmale
Wistar rats, as described by Mueller et al. (1998). First, fat
pads were minced in Krebs–Ringer HEPES buffer (pH
7.4; containing 5 mM D-glucose, 2% BSA, 135 mM NaCl,
2.2 mM CaCl2.2H2O, 1.25 mM MgSO4.7H2O, 0.45 mM
KH2PO4, 2.17 mM Na2HPO4, and 10 mM HEPES).
Secondly, tissue fragments were digested in the above
buffer supplemented with type I collagenase (1.25 mg/
ml per 0.5 g tissue; Worthington, Lakewood, NJ, USA) at
37 8C for 30 min with gentle shaking (60 cycles/min).
The resulting cell suspension was diluted in HEPES–
phosphate buffer; isolated adipocytes were then separ-
ated from the undigested tissue by filtration through a
400 mm nylon mesh and washed thrice. Isolated adipo-
cytes were resuspended inDMEMsupplementedwith 1%
FBS and incubated for 30 min at 37 8C.Plasmids
Cells were transfected with plasmids containing
different constructs of the mouse leptin promoter
preceding a luciferase reporter gene (p(K762)lep–
luc, p(K135)lep–luc, p(K95)lep–luc, p(K85)lep–luc,
m(K140 to K135), and m(K100 to K95)), kindly
provided by Dr Marc Reitman (Diabetes Branch,
National Institute of Diabetes and Digestive and
Kidney Diseases, National Institute of Health; He et al.
1995, Mason et al. 1998). Plasmid DNA was transformed
into One Shot competent cells (Original TA Cloning
Kit, Invitrogen) and all vectors were prepared using an
EndoFree Plasmid Maxi kit (Qiagen, Inc.). The
concentration of plasmid DNA was determined by
both spectrophotometry and restriction enzyme diges-
tion followed by agarose gel electrophoresis and
comparison with known DNA standards.www.endocrinology-journals.org
Sp1 and regulation of leptin . M J MORENO-ALIAGA and others 539Transient transfection of 3T3-L1 cells
Five days after the induction of differentiation, 3T3-L1
adipocytes were transfected with 6 mg plasmids
containing the leptin promoter constructs using a
calcium phosphate method (Moreno-Aliaga et al.
2001). The pRL-SV40 plasmid (4 ng), encoding Renilla
luciferase, was used to control for transfection effi-
ciency. After 16–20 h of incubation, the culture
medium was removed and cells were washed with
Dulbecco’s PBS. Cells were then incubated for 48 h in
medium containing 25 mM glucose, with or without
insulin (16 nM). The effects of 2-DG (50 mg/dl) on
leptin promoter activity in the absence or presence of
insulin (16 nM) were also examined. We have pre-
viously demonstrated that this concentration of 2-DG
induces a marked (O90%) suppression of leptin mRNA
expression and leptin secretion in primary cultured rat
adipocytes, but does not induce cytotoxic effects, as 18S
RNA was unaffected and lipoprotein lipase activity was
only modestly reduced (Mueller et al. 1998).Transient transfection of primary adipocytes by
electroporation
Analiquot of 200 ml adipocyte suspensionwas placed into
0.4 cm gap electrocuvettes containing 10 mg leptin
promoter constructs and 3.5 ng pRL-SV40 plasmid.
Cells were electroporated by administering 1 pulse at a
voltage of 200 V and a capacitance of 950 mF. After
electroporation, adipocytes were transferred to poly-
styrene tubes containing 2 ml DMEM (5 mM glucose)
with 1%fetal bovine serum(FBS)and1.6 nMinsulinwith
or without 10 mg/dl 2-DG, as reported in the results.Dual luciferase assay
After 20 h (primary adipocytes) or 48 h (3T3-L1 cells)
of treatment, cells were lysed, and firefly and Renilla
luciferase assays were performed on the lysate using the
Dual Luciferase Reporter Assay System (Promega),
according to the manufacturer’s standard protocol.Electrophoretic mobility shift assays (EMSAs)
Nuclei were isolated from primary adipocytes, treated
without or with insulin (1.6 nM) in the absence or
presence of 2-DG, according to the method of Dignam
et al. (1983) with minor modifications. Nuclear extracts
were then prepared from these nuclei by a slight
modification of the method of Lavery & Schibler
(1993). EMSA studies were performed as described
by Moreno-Aliaga & Matsumura (1999). The sequences
of double-stranded oligonucleotides for the Sp1-binding
assays were as follows: wtK112/K83 (50-GCCCGCT-
GGGTGGGGCGGGAGTTGGCGCTC-30), mutK112/Kwww.endocrinology-journals.org83 (50-GCCCGCTGGGTGaaGCttGAGTTGGCGCTC-30).
Sp1 consensus oligonucleotide (5 0-ATTCGATCGGG-
GCGGGGCGAGC-30) was obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Oligonucleotides
were end-labeled using [g-32P]ATP (Amersham Life
Sciences) and T4 polynucleotide kinase (Promega)
according to the standard methods.
Nuclear extracts (10 mg) were incubated in a buffer
containing 25 mM HEPES (pH 7.9), 10% glycerol, and
0.5 mM dithiothreitol, with 3 mg poly (d(IKC))
(Boehringer Mannheim, Indianapolis, IN, USA), and
5 mg acetylated BSA for 30 min at 4 8C. A 100-fold excess
of specific competitor was added to some samples.
Lastly, the different radiolabeled double-strand oligo-
nucleotides (50 000 c.p.m.) were added and incubated
for an additional 20 min at room temperature. For
supershift assays, a specific antibody against Sp1 (Santa
Cruz Biotechnology) was added. Oligonucleotide–
nuclear factor complexes were determined by electro-
phoresis in a non-denaturing 4% polyacrylamide gel at
150–200 V for 2–3 h. Gels were dried and exposed to
film with an intensifying screen at K80 8C.Measurement of leptin secretion, glucose utilization,
and lactate production in cultured primary rat
adipocytes
Epididymal rat adipocytes (150 ml of 2:1 ratio of packed
cells to medium), isolated as previously described, were
plated on 500 ml collagenmatrix (Vitrogen 100, Cohesion
Technologies, Palo Alto, CA, USA) in six-well culture
plates. After a 45-min incubation at 37 8C, culture media
(5 mM glucose DMEM) containing the different treat-
ments (1.6 nM insulin and/or 0.1 mM WP631) were
added, and the cells were maintained in an incubator at
37 8C in 5% CO2 for up to 48 h. Leptin concentrations in
the media were determined with an RIA for rat leptin
(Linco Research, St Charles, MO, USA). Glucose util-
ization and lactate production were assessed bymeasuring
their concentration in the media with an Autoanalyzer
(Cobas Roche Diagnostic). The amount of carbon
released as lactate per amount of carbon taken up as
glucose over 48 hwas calculated asD(lactate)/D(glucose),
where D is the change and expressed as a percentage.Real-time PCR analysis
Total RNA was extracted using TRIZOL reagent
(GIBCO-Life Technologies, Inc.) according to the
manufacturer’s instructions and incubated with
RNase-free kit DNase (Ambion, Austin, TX, USA) for
30 min at 37 8C. RNA concentrations were measured
spectrophotometrically and its quality was verified by
ethidium bromide staining after agarose gel
electrophoresis.Journal of Molecular Endocrinology (2007) 38, 537–546
M J MORENO-ALIAGA and others . Sp1 and regulation of leptin540For each sample, 1.5 mg RNA were reverse tran-
scribed to cDNA using the high-capacity cDNA archive
kit (Applied Biosystems, Foster City, CA, USA) in a total
volume of 26.6 ml. Reverse transcription was performed
under the following conditions: 60 min at 37 8C and
5 min at 95 8C. cDNA samples were then frozen at
K20 8C in several aliquots until gene expression assays
were performed.
For real-time PCR analysis, 9 ml cDNA per reaction
were used. Reagents for real-time PCR analysis of leptin,
Sp1, and 18S (Assays-on-Demand, TaqMan Universal
PCR Master mix) were purchased from Applied
Biosystems and the conditions were used according to
manufacturer’s protocol. Amplification and detection
of specific products were performed with the ABI
PRISM 7000HT Sequence Detection System (Applied
Biosystems). A standard curve was plotted for each
primer–probe set with a decimal serial dilution of
several cDNA samples to ensure that the end of the
reaction for control and different treatment samples
was in the middle of the exponential curve of
amplification.
18S ribosomal primer–probewas used tonormalize the
expression levels between samples allowing data to be
expressed relative to 18S rRNA, therefore, compensating
any difference in reverse transcriptase efficiency. All
standards and samples were analyzed as duplicates. Data
were obtained as Ct values (the cycle where the emitted
fluorescence signal is significantly above the background
levels and is inversely proportional to the initial template
copy number) according to manufacturer’s guidelines,
and used to determine DCt values (DCtZCt of the target
gene – Ct of the housekeeping gene 18S) of each sample.
Fold changes of gene expression were calculated by the
2KDDCt method (Livak & Schmittgen 2001).Statistical analysis
For the transfection studies, the means were
compared by one-way ANOVA followed by a
Bonferroni’s post hoc test (GraphPad Prism, Graph-
Pad Software, San Diego, CA, USA). The statistical
analysis of the effects of WP631 on leptin secretion,
glucose utilization and the percentage of glucose
converted to lactate were performed by a repeated-
measures ANOVA followed by a Bonferroni’s post hoc
test, because of the high variability between
adipocytes cultures from different rats; for this
reason, the experimental results from each adipo-
cyte suspension prepared from a single animal were
analyzed in relation to a control well from the
same suspension (Perez-Matute et al. 2005). Differ-
ences were considered as statistically significant at
P!0.05.Journal of Molecular Endocrinology (2007) 38, 537–546Results
Identification of cis-acting DNA sequences involved in
the regulation of leptin gene by glucose metabolism
To define the cis-acting DNA sequences required for the
upregulation of leptin gene by insulin-mediated
glucose metabolism, we performed a deletion analysis
of the leptin promoter in differentiated 3T3-L1
adipocytes and primary rat adipocytes. 3T3-L1 cells
were transiently transfected with a series of reporter
constructs containing various portions of the leptin
promoter sequence. Previous studies have shown that
the proximal promoter (up to K161 bp from the
transcriptional start site) is sufficient for leptin
expression in adipocytes (He et al. 1995).
As shown in Fig. 1, insulin and glucose-stimulated
reporter gene activity of the K762 and K135
constructs at least twofold in 3T3-L1 adipocytes.
This increase was abolished by incubation with
2-DG (data not shown). In contrast, a marked
reduction in insulin-stimulated luciferase activity was
observed when reporter genes of K95 and K85 bp
were transfected. Similar results were observed in
primary adipocytes transfected with the K135 and
K95 constructs (Fig. 2). The transcriptional activity
of the leptin promoter, as assessed by increased
luciferase activity, was increased threefold in the
presence of a physiological concentration of insulin
(1.6 nM) in cells transfected with the p(K135)
construct but was unaffected in the p(K95) con-
struct. Furthermore, the increase of transcriptional
activity induced by insulin was abolished by co-
incubation with the inhibitor of glucose metabolism,
2-DG. Thus, these data indicate that the cis-acting
DNA sequence which mediates the activation of the
leptin promoter in response to insulin-stimulated
glucose metabolism is located between positions
K135 and K95 of the leptin gene.
The sequence centered at K97 is an exact match to
Sp1 core motif sequence (Mason et al. 1998). To study
the contribution of this region of the promoter to the
insulin and glucose responsiveness, primary adipocytes
were transfected with a plasmid m(K100/K95)
containing four point mutations between bases K100
and K95. These mutations resulted in a loss of
promoter activation (Fig. 3). As a control, we also
transfected a mutated K140/K135 construct, which
contains an intact Sp1 sequence centered on K97. In
primary cells transfected with this construct, insulin
induced a twofold increase of transcriptional activity
that was abolished by 2-DG. Together, the results
demonstrate that mutation of the Sp1 site, but not an
upstream site, results in a loss of responsiveness to
insulin-stimulated glucose metabolism.www.endocrinology-journals.org
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Figure 1 Locations of insulin-mediated glucose metabolism
regulatory sequences in the leptin promoter in 3T3-L1 adipo-
cytes. Cells were transfected with theK762,K135,K95, and
K85 bp plasmid constructs and treated for 48 h without or with
insulin (16 nM). A pRL-SV40 plasmid was co-transfected to
control for transfection efficiency. ThemeanGS.E.M. of at least four
independent experiments is shown.
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Figure 3 Effects of insulin and 2-DG in cells transfected with the
mutant plasmids m(K140/K135) and m(K100/K95) of leptin
promoter in primary rat adipocytes. Cells were treated for 20 h
without or with insulin (1.6 nM) in the absence or presence of 2-
DG (10 mg/dl). A pRL-SV40 plasmid was co-transfected to control
for transfection efficiency. Data are expressed as fold of increase
of the activity in the absence of insulin. The meanGS.E.M. of six
independent experiments is shown. *P!0.05 compared with the
control cells. aP!0.05 compared with the insulin-treated group.
Sp1 and regulation of leptin . M J MORENO-ALIAGA and others 541Identification of trans-acting factor involved in the
regulation of the leptin gene by glucose metabolism
The data from the previous experiments suggest that
the transcription factor, Sp1, mediates the activation of
the leptin promoter in response to insulin-stimulated
glucose metabolism. While previous studies have
reported that Sp1 binds to this site (or to its equivalent
in the rat gene; Mason et al. 1998, Fukuda & Iritani
1999), there are currently no available data addressing
whether this Sp1-mediated transcription is regulated by
insulin-stimulated glucose metabolism. To test this
hypothesis, EMSAs were performed with adipocyte5
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Figure 2 Effects of 2-DG on the action of insulin on leptin promoter
activity in primary rat adipocytes. Cells were transfected with the
p(K135)lep–luc or p(K95)lep–luc plasmids and treated for 20 h
without or with insulin (1.6 nM) in the absence or presence of 2-
DG (10 mg/dl). A pRL-SV40 plasmid was co-transfected to control
for transfection efficiency. Data are expressed as fold of increase
of the activity in the absence of insulin. The meanGS.E.M. of six
independent experiments is shown. *P!0.05 compared with the
control cells. aP!0.05 compared with the insulin-treated group.
www.endocrinology-journals.orgnuclear extracts from control and insulin-treated cells
(in the absence or presence of 2-DG).
Usingnuclear extracts fromcells treated in the absence
of insulin, DNA–protein complexes of the same mobility
were observed for the wild-type sequence of the leptin
promoter from bases K112 to K83 (wt(K112/K83),
Fig. 4, lane 1) and for an Sp1 consensus oligonucleotide
(lane 8). Subsequently, treatment with insulin (1.6 nM)
increased the abundance of the Sp1–DNA complex (lane
1 versus lane 2 and lane 8 versus lane 9), and this increase
was abolished by the addition of 50 mg/dl 2-DG (lanes 3
and 10). The intensity of the Sp1–DNA complexes was
also markedly decreased upon preincubation with an
antibody directed against Sp1, indicating that Sp1 is
present in the complex (lanes 4–6 and 11). The specific
bindingofSp1 to thewtK112/K83probewas eliminated
by competition with an excess of homologous unlabeled
probe (lane7). Also,mutationoffourbases in theSp1 site
(in oligonucleotide m(K112/K83)) prevented the
formation of a DNA–Sp1 protein complex under these
conditions (lanes 12–14).Inhibition of Sp1-mediated transcription prevents the
stimulatory effects of insulin-stimulated glucose
metabolism on leptin secretion
To verify that increased leptin secretion in response to
insulin-stimulated glucose metabolism involves Sp1-
mediated transcription, primary adipocytes were incu-
bated with WP631, a bisintercalating anthracycline
drug, which specifically inhibits Sp1-dependent tran-
scription (Botella et al. 2001, Mansilla et al. 2004).Journal of Molecular Endocrinology (2007) 38, 537–546
Probe wt(–112/–83) Spl m(–112/–83)
Competition #
Spl-Ab − − − + + + − − − − + − − −
2-DG − − + − − + − − − + − − − +
Insulin − + + − + + − − + + + − + +
Lane no. 1 2 3 4 8 9 10 12 13 14115 6 7
Spl-DNA
Figure 4 Effects of 2-DG on insulin-stimulated binding of Sp1 to its consensus sequence in the leptin
promoter. Gel shift analysis was performed in nuclear extracts prepared from primary rat adipocytes treated
for 24 h without or with insulin (1.6 nM) in the absence or presence of 2-DG (50 mg/dl). Sp1 consensus
oligonucleotide and wild-type (wtK112/K83) and mutant (mK112/K83) oligonucleotide sequences of the
leptin promoter were used as probes. For supershift complexes, nuclear extracts were also incubated with a
specific anti-Sp1 antibody. #A competition assay using a 100-fold excess of corresponding unlabeled
oligonucleotide was performed to obtain non-specific-binding activity. Each shift is representative of three
independent experiments.
M J MORENO-ALIAGA and others . Sp1 and regulation of leptin542Treatment with WP631 (0.1 mM) for 48 h had no effect
on basal leptin secretion in cultured primary rat
adipocytes, but completely suppressed insulin-stimu-
lated leptin secretion (Fig. 5A). These results were
confirmed by RT-PCR, where the insulin-stimulated
increase in leptin mRNA expression was blocked by
WP631 (Fig. 5B). The effects of WP631 on glucose
utilization and lactate production were also
determined. Figure 5C and D shows that WP631Journal of Molecular Endocrinology (2007) 38, 537–546treatment did not significantly modify either glucose
utilization or the percentage of glucose carbon
released as lactate, suggesting that the compound
does not exert non-specific effects on cellular metab-
olism which could affect insulin stimulation of leptin
secretion. Therefore, the suppression of insulin-stimu-
lated leptin secretion caused by WP631 (0.1 mM) is
likely to be due to its inhibitory properties of Sp1-
dependent transcription.www.endocrinology-journals.org
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Figure 5 Effects of WP631 on basal and insulin-stimulated leptin secretion (A), leptin gene expression (B),
glucose utilization (C), and the percentage of glucose carbon released as lactate (D) after 48 h of culture.
Isolated adipocytes were incubated in the absence or presence of insulin (1.6 nM) with WP631 (0.1 mM).
NZ8. *P!0.05, **P!0.01, ***P!0.001 compared with control (basal group). aP!0.05, cP!0.001
compared with the insulin-stimulated group.
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Figure 6 Effects of okadaic acid (OA 25 and 500 nM) on insulin-
stimulated leptin secretion in cultured adipocytes. NZ6 in all
groups. *P!0.05 compared with control group. bP!0.01 and
cP!0.001 compared with the insulin-stimulated group.
Sp1 and regulation of leptin . M J MORENO-ALIAGA and others 543Effects of okadaic acid (OA) on insulin-stimulated
leptin expression and secretion
Several studies have demonstrated that changes in
the phosphorylation status of Sp1 are controlling the
ability of this transcription factor to bind to DNA
(Samson & Wong 2002). The effects of okadaic acid
(OA), a potent phosphatase inhibitor, on leptin gene
expression and protein secretion were also examined.
The results showed that both leptin secretion (Fig. 6)
and leptin mRNA levels (data not shown) were
inhibited by OA from the first 4 h of culture in
primary adipocytes.
In addition, our data showed that the expression
levels of Sp1 were not changed as a result of insulin
treatment of adipocytes, suggesting that the overall
quantity of Sp1 does not seem to be increased (data not
shown).
Together, these data suggest a potential role for
dephosphorylation, likely involving Sp1 in the tran-
scriptional regulation of leptin by insulin-stimulated
glucose metabolism.www.endocrinology-journals.org Journal of Molecular Endocrinology (2007) 38, 537–546
M J MORENO-ALIAGA and others . Sp1 and regulation of leptin544Discussion
The present study was conducted to investigate the
mechanisms by which insulin-stimulated glucose metab-
olism stimulates leptin secretion in adipocytes. Leptin is
a major determinant of body weight/adiposity in
mammals via its actions to regulate both food intake
and energy expenditure (Havel 2004). A thorough
understanding of the mechanisms regulating leptin
synthesis and secretion may yield new therapeutic
strategies to prevent recidivism following weight loss
(Rosenbaum et al. 2005). We have previously reported
that insulin-stimulated glucose metabolism, rather than
a direct action of insulin itself, is a major determinant of
leptin production in adipocytes (Mueller et al. 1998,
2000, Moreno-Aliaga et al. 2001), and our findings have
been corroborated by in vivo data from human subjects
(Wellhoener et al. 2000). In the present study, we first
identified a region of the leptin promoter (K135 to
K95 bp, relative to the transcription start site) required
to increase the transcriptional activity of the leptin
promoter in response to insulin-stimulated glucose
metabolism in 3T3-L1 cells and in primary cultured rat
adipocytes. This sequence contains a consensus Sp1
site, centered at K97 bp, and a mutation of four
nucleotides at this site, but not at an upstream site,
prevents the increase of transcription induced by
insulin. Again, this was demonstrated to be mediated
by insulin-stimulated glucose metabolism as it was
abolished by co-incubation with 2-DG, a competitive
inhibitor of glucose uptake and phosphorylation. This
inhibitory effect of 2-DG is unlikely to be due to a
depletion of adipocyte energy stores, as it is known that
adipocytes can generate energy (ATP) by oxidizing fatty
acids via mitochondrial b-oxidation (Mayers 1993,
Moore et al. 1996). Using gel shift assays, we showed
that insulin increased the binding of Sp1 to this site,
and that formation of the Sp1–DNA complex in
response to insulin was prevented by treatment with
2-DG, demonstrating a requirement for glucose metab-
olism. Consistent with these results, we also found that
incubating primary adipocyte cultures with a specific
inhibitor of Sp1-mediated transcription had no effect
on basal leptin secretion, but completely prevented the
increase of leptin secretion induced by insulin.
Sp1 is a ubiquitously expressed transcription factor
that recognizes GC-rich sequences and may function as
a cellular glucose sensor (Vaulont et al. 2000). Low
glucose levels have been shown to attenuate the DNA-
binding activity of Sp1 via hypo-GlcNAcylation (Kang
et al. 2003), a post-translational modification that
involves the covalent linkage of the monosaccharide
O-GlcNAc to serine and threonine residues. In this case,
this is followed by proteolytic degradation (Han &
Kudlow 1997). Interestingly, Kang et al. (2003) have
reported that 2-DG downregulates Sp1 activity,Journal of Molecular Endocrinology (2007) 38, 537–546although via hyper-GlcNAcylation, which does not
attenuate Sp1’s DNA-binding activity but rather appears
to interfere with its activation domain. In our previous
study (Moreno-Aliaga et al. 2001), we did not detect
significant changes in leptin promoter activity in
response to 2-DG in the absence of insulin, suggesting
that its effects on the leptin promoter are specific for
insulin-mediated glucose metabolism. Other genes
regulated by Sp1 in response to glucose include ACC
(Daniel & Kim 1996), aldolase A and pyruvate kinase
M2 (Schafer et al. 1997), and plasminogen activator
inhibitor-1 (Chen et al. 1998). Sp1 and the closely
related Sp3 transcription factors also appear to be
involved in glucose- and insulin-dependent expression
of fatty acid synthase and ATP citrate-lyase (Fukuda et al.
1999). A growing body of evidence suggests that the
DNA-binding and transcription activity of Sp1 may
increase or decrease in response to changes in
phosphorylation (Samson & Wong 2002, Lam et al.
2003). Thus, dephosphorylation of Sp1 by protein
phosphatase 1 has been involved in the glucose-
mediated activation of the acetyl-CoA carboxylase,
aldolase, and pyruvate kinase (Daniel et al. 1996,
Schafer et al. 1997). Our data also suggest a potential
role for dephosphorylation, likely involving Sp1 in the
transcriptional regulation of leptin by insulin-stimu-
lated glucose metabolism.
Although the Sp1 site in the leptin promoter has
been identified in prior studies (Mason et al. 1998,
Fukuda & Iritani 1999), the present work is significant
and novel in that we identified this site by determining
which regions of the promoter were required to
stimulate leptin transcription in response to insulin-
stimulated glucose metabolism. Moreover, our finding
that inhibition of Sp1-mediated transcription (with
WP631) prevents the increase in leptin secretion from
adipocytes cultured in the presence of glucose and
insulin has not been previously reported.
The present results conflict with those previously
reported in some other studies, however, Fukuda &
Iritani (1999) also found that Sp1 bound to the
equivalent site in the rat leptin promoter, but their
data suggested that Sp1 inhibited leptin transcription
in adipocytes. The authors constructed a reporter gene
containing two copies of the K101 to K83 bp leptin
promoter sequence, which was then transfected into
adipocytes cultured in 20 mM glucose and 0.1 mM
insulin. When an Sp1 expression vector was co-trans-
fected, a significant inhibition of transcription was
observed after 48 h. Mutation of the Sp1 site in their
reporter gene also resulted in a loss of responsiveness to
glucose and insulin, leading the authors to conclude
that Sp1 might inactivate leptin transcription by
binding to this sequence. The discrepancies between
the present study and the findings of Fukuda & Iritani
(1999) may be resolved by considering that native leptinwww.endocrinology-journals.org
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were not assessed in their study, and that the reporter
gene used to perform the experiments was relatively
simple (they used two repeats of a 19 bp sequence
compared with the larger 135 bp promoter sequence in
the present study). Moreover, it is plausible that binding
sites for additional transcription factors, such as
C/enhancer binding protein (EBP)-a (He et al. 1995),
may be required to accurately assess the full response to
Sp1 co-transfection. Finally, the concentrationsof glucose
and insulin in those previous studies were much higher
than we employed in the present study (5 mM and
1.6 nM), which are within the physiological range.
However, their data concerning the binding of Sp1 to
this sequence and concomitant increase in transcrip-
tional activity in response to glucose and insulin
treatment are entirely consistent with the present study.
Other investigators (Wang et al. 2000) have identified
a glucose- and insulin-responsive element in the
sequence between K1698 and K1692 bp of the
mouse leptin promoter. Glucose and insulin prevented
the binding of a nuclear protein to this promoter
element. The authors did not detect any glucose/
insulin-responsive region in the mouse proximal
promoter after transfection of 3T3-L1 adipocytes with
constructs with serial deletions of the mouse leptin
promoter. We do not dispute their results; however, we
maintain that the elements controlling expression of
leptin in adipocytes are likely to be proximal, as others
have found that deletion of basesK762 toK135 of the
leptin promoter does not compromise its expression in
adipocytes (He et al. 1995, Mason et al. 1998). Our view
is further supported by the results of Zhang et al.
(2002), who found evidence for a glucose-responsive
element is located within the proximal portion of the
human leptin promoter (K219 to C29 bp). It must
also be mentioned that the proximal w150 bp of the
leptin promoter is highly conserved (60–80%) between
mice, rats, and humans (as represented on the VISTA
Genome Browser, available at www.pipeline.lbl.gov
(Couronne et al. 2003)).
In summary, the results of this study reveal a role for
the ubiquitous transcription factor Sp1 in the
regulation of leptin synthesis and secretion in response
to insulin-stimulated glucose metabolism in adipocytes.
First, we identified the region (K135 toK95 bp) of the
proximal promoter that mediates the increase in leptin
transcription in response to glucose and insulin, and
found that mutation of a consensus Sp1-binding site
abolished this response. Next, we demonstrated that
the binding of Sp1 to this site was increased in response
to insulin treatment, and was inhibited when glucose
metabolism is blocked by 2-DG treatment. To sub-
sequently confirm the involvement of Sp1 in this
process, we found that inhibition of Sp1-mediated
transcription prevented insulin-stimulated leptinwww.endocrinology-journals.orgsecretion in adipocytes. These novel findings are
consistent with the known role of Sp1 as a mediator
of transcriptional events in response to glucose
(Vaulont et al. 2000) and significantly enhance our
understanding of how leptin synthesis and secretion by
adipocytes are linked to changes in glucose metabolism
and nutritional status in mammals.Acknowledgements
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